These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19721393)

  • 1. Ceramide mediates inhibition of the AKT/eNOS signaling pathway by palmitate in human vascular endothelial cells.
    Xiao-Yun X; Zhuo-Xiong C; Min-Xiang L; Xingxuan H; Schuchman EH; Feng L; Han-Song X; An-Hua L
    Med Sci Monit; 2009 Sep; 15(9):BR254-61. PubMed ID: 19721393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free fatty acids inhibit insulin signaling-stimulated endothelial nitric oxide synthase activation through upregulating PTEN or inhibiting Akt kinase.
    Wang XL; Zhang L; Youker K; Zhang MX; Wang J; LeMaire SA; Coselli JS; Shen YH
    Diabetes; 2006 Aug; 55(8):2301-10. PubMed ID: 16873694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceramide mediates inhibition of the Akt/eNOS pathway by high levels of glucose in human vascular endothelial cells.
    Wang A; Li C; Liao J; Dong M; Xiao Z; Lei M
    J Pediatr Endocrinol Metab; 2013; 26(1-2):31-8. PubMed ID: 23457308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Akt/eNOS signaling pathway mediates inhibition of endothelial progenitor cells by palmitate-induced ceramide.
    Fu M; Li Z; Tan T; Guo W; Xie N; Liu Q; Zhu H; Xie X; Lei H
    Am J Physiol Heart Circ Physiol; 2015 Jan; 308(1):H11-7. PubMed ID: 25380816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of insulin and Akt1 signaling to endothelial nitric oxide synthase in the regulation of endothelial function and blood pressure.
    Symons JD; McMillin SL; Riehle C; Tanner J; Palionyte M; Hillas E; Jones D; Cooksey RC; Birnbaum MJ; McClain DA; Zhang QJ; Gale D; Wilson LJ; Abel ED
    Circ Res; 2009 May; 104(9):1085-94. PubMed ID: 19342603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids.
    Chavez JA; Knotts TA; Wang LP; Li G; Dobrowsky RT; Florant GL; Summers SA
    J Biol Chem; 2003 Mar; 278(12):10297-303. PubMed ID: 12525490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 impairs the insulin signaling pathway, promoting production of nitric oxide in human umbilical vein endothelial cells.
    Andreozzi F; Laratta E; Procopio C; Hribal ML; Sciacqua A; Perticone M; Miele C; Perticone F; Sesti G
    Mol Cell Biol; 2007 Mar; 27(6):2372-83. PubMed ID: 17242212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propionyl-L-carnitine induces eNOS activation and nitric oxide synthesis in endothelial cells via PI3 and Akt kinases.
    Ning WH; Zhao K
    Vascul Pharmacol; 2013; 59(3-4):76-82. PubMed ID: 23850990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct apoptotic effects of free fatty acids on human endothelial cells.
    Piro S; Spampinato D; Spadaro L; Oliveri CE; Purrello F; Rabuazzo AM
    Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):96-104. PubMed ID: 17560770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes.
    Chavez JA; Summers SA
    Arch Biochem Biophys; 2003 Nov; 419(2):101-9. PubMed ID: 14592453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tonic inhibition by G protein-coupled receptor kinase 2 of Akt/endothelial nitric-oxide synthase signaling in human vascular endothelial cells under conditions of hyperglycemia with high insulin levels.
    Taguchi K; Sakata K; Ohashi W; Imaizumi T; Imura J; Hattori Y
    J Pharmacol Exp Ther; 2014 May; 349(2):199-208. PubMed ID: 24570070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex.
    Zhang QJ; Holland WL; Wilson L; Tanner JM; Kearns D; Cahoon JM; Pettey D; Losee J; Duncan B; Gale D; Kowalski CA; Deeter N; Nichols A; Deesing M; Arrant C; Ruan T; Boehme C; McCamey DR; Rou J; Ambal K; Narra KK; Summers SA; Abel ED; Symons JD
    Diabetes; 2012 Jul; 61(7):1848-59. PubMed ID: 22586587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty acid-induced defects in insulin signalling, in myotubes derived from children, are related to ceramide production from palmitate rather than the accumulation of intramyocellular lipid.
    Sabin MA; Stewart CE; Crowne EC; Turner SJ; Hunt LP; Welsh GI; Grohmann MJ; Holly JM; Shield JP
    J Cell Physiol; 2007 Apr; 211(1):244-52. PubMed ID: 17219404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceramide-Initiated Protein Phosphatase 2A Activation Contributes to Arterial Dysfunction In Vivo.
    Bharath LP; Ruan T; Li Y; Ravindran A; Wan X; Nhan JK; Walker ML; Deeter L; Goodrich R; Johnson E; Munday D; Mueller R; Kunz D; Jones D; Reese V; Summers SA; Babu PV; Holland WL; Zhang QJ; Abel ED; Symons JD
    Diabetes; 2015 Nov; 64(11):3914-26. PubMed ID: 26253611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced NO-cGMP signaling contributes to vascular inflammation and insulin resistance induced by high-fat feeding.
    Rizzo NO; Maloney E; Pham M; Luttrell I; Wessells H; Tateya S; Daum G; Handa P; Schwartz MW; Kim F
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):758-65. PubMed ID: 20093624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells.
    Andreozzi F; Laratta E; Sciacqua A; Perticone F; Sesti G
    Circ Res; 2004 May; 94(9):1211-8. PubMed ID: 15044323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin (1-7) counteracts the negative effect of angiotensin II on insulin signalling in HUVECs.
    Tassone EJ; Sciacqua A; Andreozzi F; Presta I; Perticone M; Carnevale D; Casaburo M; Hribal ML; Sesti G; Perticone F
    Cardiovasc Res; 2013 Jul; 99(1):129-36. PubMed ID: 23524303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIB3 R84 variant is associated with impaired insulin-mediated nitric oxide production in human endothelial cells.
    Andreozzi F; Formoso G; Prudente S; Hribal ML; Pandolfi A; Bellacchio E; Di Silvestre S; Trischitta V; Consoli A; Sesti G
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1355-60. PubMed ID: 18436806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstituted high-density lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of phosphatidylinositol 3-kinase but not Akt/endothelial nitric oxide synthase.
    Viswambharan H; Ming XF; Zhu S; Hubsch A; Lerch P; Vergères G; Rusconi S; Yang Z
    Circ Res; 2004 Apr; 94(7):918-25. PubMed ID: 14988229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palmitic and linoleic acids impair endothelial progenitor cells by inhibition of Akt/eNOS pathway.
    Guo WX; Yang QD; Liu YH; Xie XY; Wang-Miao ; Niu RC
    Arch Med Res; 2008 May; 39(4):434-42. PubMed ID: 18375256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.